In particular, the detection of SEPT9 gene hypermethylation one month after surgery has demonstrated excellent performance in identifying tumor recurrence, with reported sensitivity and specificity rates close to 100% and 94.7%, respectively [44]. This evidence concerns the gene SEPTIN9 and neoplasm.